Dulaglutide (Trulicity) studies: 418 papers with results
Page 6 of 9
- Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs.
Popoviciu MS · Biomedicines · 2025
Observational study · 9 results
- The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy.
Barrett A · Journal of medical economics · 2024
Observational study · 3 results
- Optimal Glycemic Control in a Patient With HNF1A MODY With GLP-1 RA Monotherapy: Implications for Future Therapy.
Fantasia KL · Journal of the Endocrine Society · 2019
Case report or series · 2 results
- GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report.
Zhang J · Medicine · 2024
Case report or series · 6 results
- No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.
Sherman SI · Diabetic medicine : a journal of the British Diabetic Association · 2018
Case report or series · 1 result
- Tirzepatide-Induced Injection Site Reaction.
Mizumoto J · Cureus · 2023
Case report or series · 3 results
- An Uncommon Case of Dulaglutide-Related Morbilliform Drug Eruption.
Kyriakos G · Cureus · 2022
Case report or series · 1 result
- A Rare Case of Dulaglutide-Associated Angioedema in a Male Patient.
Karakousis N · Cureus · 2021
Case report or series · 1 result
- Dulaglutide (Trulicity)-Induced Acute Pancreatitis: A Case Report.
Khan AB · Cureus · 2023
Case report or series · 5 results
- Vitreous hemorrhage during GLP-1 receptor agonist treatment.
Kim DS · Journal of the American Pharmacists Association : JAPhA · 2023
Case report or series · 5 results
- Dulaglutide use to improve binge eating behaviors in a person with type 2 diabetes and obesity.
Innocent B · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2025
Case report or series · 2 results
- A Case of Dulaglutide-Induced Vaginal Bleed.
Vaccaro CJ · Cureus · 2023
Case report or series · 3 results
- Euglycemic Diabetic Ketoacidosis in the Setting of Dulaglutide Use.
Patel N · Cureus · 2025
Case report or series · 2 results
- Unmasking Euglycemic Diabetic Ketoacidosis: The Interplay of Pregnancy, Sepsis, and Glucagon-Like Peptide 1 Analog.
Huang A · Cureus · 2025
Case report or series · 1 result
- Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide.
Sawamura T · Medicina (Kaunas, Lithuania) · 2022
Case report or series · 4 results
- ADDITION OF DULAGLUTIDE FOR A HIGH-DOSE INSULIN REQUIRING PATIENT WITH TYPE 2 DIABETES MELLITUS: A REMARKABLE RESPONSE.
Kazim M · AACE clinical case reports · 2019
Case report or series · 3 results
- Acute Kidney Injury from Mononuclear Cell-Predominated Interstitial Nephritis After Introduction of a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report.
Itsathitpaisarn R · The American journal of case reports · 2025
Case report or series · 3 results
- Dulaglutide as a Bridging Therapy Before Insulin for Diabetes Following Pancreatectomy on Congenital Hyperinsulinism.
Motegi S · JCEM case reports · 2026
Case report or series · 5 results
- Acute Pancreatitis After Initiating Dulaglutide in a Patient Previously Treated With a DPP-4 Inhibitor: Case Report From Palestine.
Nasser A · Case reports in gastrointestinal medicine · 2025
Case report or series · 7 results
- Significant elevation of serum CA19-9 and CA242 levels induced by dulaglutide.
Shi X · BMJ case reports · 2024
Case report or series · 4 results
- PSUN270 Magnified Risk of Pancreatitis by GLP-1: A Case of Necrotizing Pancreatitis in a Patient on Dulaglutide with Baseline Elevated Triglycerides
Journal of the Endocrine Society · 2022
Case report or series · 3 results
- PSUN241 A Case of Dulaglutide-Induced Acute Pancreatitis in a Diabetic Patient – A Case Report
Journal of the Endocrine Society · 2022
Case report or series · 3 results
- Necrotizing Pancreatitis Secondary to Dulaglutide Use
Bhat S · Journal of the Endocrine Society · 2021
Case report or series · 26 results
- Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
Quadri H · Journal of the Endocrine Society · 2021
Case report or series · 6 results
- An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg.
Pratley RE · Diabetes, obesity & metabolism · 2021
Other design · 8 results
- The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis.
Wilson JM · Diabetes, obesity & metabolism · 2022
Other design · 25 results
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.
Hartman ML · Diabetes care · 2020
Other design · 10 results
- Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial.
Frias JP · Diabetes, obesity & metabolism · 2021
Other design · 12 results
- A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules.
Posada MM · CPT: pharmacometrics & systems pharmacology · 2025
Other design · 2 results
- Effects of Dulaglutide on Thyroid C Cells and Serum Calcitonin in Male Monkeys.
Vahle JL · Endocrinology · 2015
Animal study (in vivo) · cynomolgus monkey · 7 results
- Effects of the GLP-1 Receptor Agonist Dulaglutide on the Structure of the Exocrine Pancreas of Cynomolgus Monkeys.
Vahle JL · Toxicologic pathology · 2015
Animal study (in vivo) · cynomolgus monkeys · 12 results
- Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
Murakami T · Journal of diabetes investigation · 2020
Animal study (in vivo) · mouse · 5 results
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.
Glaesner W · Diabetes/metabolism research and reviews · 2010
Animal study (in vivo) · monkey, mouse and rat · 11 results
- Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy.
Hong Y · Journal of cachexia, sarcopenia and muscle · 2019
Animal study (in vivo) · mouse · 2 results
- Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
Zhou M · Biochemical and biophysical research communications · 2019
Animal study (in vivo) · mouse · 6 results
- Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats.
Vallöf D · Translational psychiatry · 2020
Animal study (in vivo) · rat · 5 results
- Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH.
Hupa-Breier KL · Biomedicines · 2021
Animal study (in vivo) · mouse · 12 results
- Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model.
Park HJ · Scientific reports · 2019
Animal study (in vivo) · mouse · 36 results
- Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better.
Sanada J · Scientific reports · 2021
Animal study (in vivo) · mouse · 8 results
- Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
Chiou HC · International journal of molecular sciences · 2019
Animal study (in vivo) · mouse · 7 results
- Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.
Kimura T · Diabetes & metabolism · 2018
Animal study (in vivo) · mouse · 12 results
- Long-Term Activation of Glucagon-like peptide-1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes.
Xie S · Journal of the American Heart Association · 2022
Animal study (in vivo) · mouse · 12 results
- Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice.
Khin PP · Aging · 2021
Animal study (in vivo) · mouse · 17 results
- Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM · Peptides · 2021
Animal study (in vivo) · rat · 7 results
- Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts.
Deng F · International journal of endocrinology · 2023
Animal study (in vivo) · mouse · 9 results
- Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial-Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway.
Wang Y · Pharmaceuticals (Basel, Switzerland) · 2023
Animal study (in vivo) · mouse · 21 results
- Dulaglutide provides protection against sepsis-induced lung injury in mice by inhibiting inflammation and apoptosis.
Wang Y · European journal of pharmacology · 2023
Animal study (in vivo) · mouse · 17 results
- Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents.
Byrd RA · Endocrinology · 2015
Animal study (in vivo) · mouse and rat · 13 results
- Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1.
Shamardl HAMA · Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2023
Animal study (in vivo) · rat · 3 results
- Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway.
Mahdy RNE · Naunyn-Schmiedeberg's archives of pharmacology · 2025
Animal study (in vivo) · rat · 17 results